Peltz's addition should pacify a persistent critique of the company.
Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
The plan is for Peltz to help the firm in maximizing potential markets to target.
Themes like cannabis tend to persist longer than many think they will.
This $12 billion industry could rise to around $630 billion over time, according to Seaport analysts.
Strength in Apple and other FANG names are pluses, as are pockets of action in gold mining, cannabis, biotechnology and shipping.
In its first report on cannabis companies, Melius says prices are high.
And why I won't recommend any other stocks in these markets, right now.